Breaking News, Trials & Filings

Trials & Filings in Brief: Oct. 29, 2013

Ablynx, Alvine, Boehringer, Charleston, Innovus, Lumena, Merck, PharmaLink

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I
Boehringer tests Ablynx Nanobody in AD . . . read more

Merck presents interim NSCLC data for PD-1 inhibitor . . . read more

Phase II
Alvine begins celiac trial . . . read more

Lumena begins PBC trial . . . read more

Phase III
Charleston ends painkiller trial early . . . read more

Filings
Innovus files EjectDelay in Canada . . . read more

Pharmalink gets orphan status for Busulipo . . . read more

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters